FIG 4.
Forest plot to show variation in progression-free survival treatment effect with respect to (A) minimization factors and (B) whether patients were found to be DRD biomarker–positive on the basis of an alteration in a prespecified list of DNA repair genes, or because of ≥ 10% LOH, or both. %LOH, percentage genome-wide loss of heterozygosity; DRD, DNA repair deficiency; ECOG PS, Eastern Cooperative Oncology Group performance status; HR, hazard ratio.